AR103977A1 - PEPTIDES, METHOD FOR DETECTING CHAGAS DISEASE, KIT AND VACCINE - Google Patents
PEPTIDES, METHOD FOR DETECTING CHAGAS DISEASE, KIT AND VACCINEInfo
- Publication number
- AR103977A1 AR103977A1 ARP160100738A ARP160100738A AR103977A1 AR 103977 A1 AR103977 A1 AR 103977A1 AR P160100738 A ARP160100738 A AR P160100738A AR P160100738 A ARP160100738 A AR P160100738A AR 103977 A1 AR103977 A1 AR 103977A1
- Authority
- AR
- Argentina
- Prior art keywords
- seq
- vaccine
- peptides
- kit
- chagas disease
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Péptido que tiene reactividad con sueros de personas con la enfermedad de Chagas. El péptido es puede ser una de las siguientes 28 secuencias SEQ ID Nº 1, SEQ ID Nº 2, SEQ ID Nº 3, SEQ ID Nº 4, SEQ ID Nº 5, SEQ ID Nº 6, SEQ ID Nº 7, SEQ ID Nº 8, SEQ ID Nº 9, SEQ ID Nº 10, SEQ ID Nº 11, SEQ ID Nº 12, SEQ ID Nº 13, SEQ ID Nº 14, SEQ ID Nº 15, SEQ ID Nº 16, SEQ ID Nº 17, SEQ ID Nº 18, SEQ ID Nº 19, SEQ ID Nº 20, SEQ ID Nº 21, SEQ ID Nº 22, SEQ ID Nº 23, SEQ ID Nº 24, SEQ ID Nº 25, SEQ ID Nº 26, SEQ ID Nº 27, SEQ ID Nº 28. El péptido puede comprender una cisteína en el extremo C-terminal y puede ser conjugado con BSA-maleimida a la cisteína terminal.Peptide that has reactivity with sera from people with Chagas disease. The peptide is can be one of the following 28 sequences SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, SEQ ID No. 4, SEQ ID No. 5, SEQ ID No. 6, SEQ ID No. 7, SEQ ID No. 8 , SEQ ID No. 9, SEQ ID No. 10, SEQ ID No. 11, SEQ ID No. 12, SEQ ID No. 13, SEQ ID No. 14, SEQ ID No. 15, SEQ ID No. 16, SEQ ID No. 17, SEQ ID No. 18 , SEQ ID No. 19, SEQ ID No. 20, SEQ ID No. 21, SEQ ID No. 22, SEQ ID No. 23, SEQ ID No. 24, SEQ ID No. 25, SEQ ID No. 26, SEQ ID No. 27, SEQ ID No. 28 The peptide may comprise a cysteine at the C-terminal end and may be conjugated with BSA-maleimide to the terminal cysteine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562135482P | 2015-03-19 | 2015-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103977A1 true AR103977A1 (en) | 2017-06-14 |
Family
ID=59256528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100738A AR103977A1 (en) | 2015-03-19 | 2016-03-18 | PEPTIDES, METHOD FOR DETECTING CHAGAS DISEASE, KIT AND VACCINE |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR103977A1 (en) |
-
2016
- 2016-03-18 AR ARP160100738A patent/AR103977A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2722773T3 (en) | Modified Meningococcal fHbp Polypeptides | |
| CL2018000124A1 (en) | New peptides and new combinations of peptides for use in immunotherapy against epithelial ovarian cancer and other types of cancer | |
| CL2018003148A1 (en) | Fusion proteins and uses thereof. | |
| EA201990071A1 (en) | PEPTIDE VACCINE COMPOSITION | |
| ECSP19034870A (en) | SLIPPABLE PEPTIDES AND INSECTICIDED AND NEMATICIDED PROTEINS THAT UNDERSTAND THEM | |
| NI201600028A (en) | POLYPEPTIDE FOR THE HYDROLYTIC EXCISION OF ZEARALENONE AND / OR DERIVATIVES OF ZEARALENONE, POLYNUCLEOTIDE ISOLATED FROM THE SAME AND POLYEPTIDE CONTAINING ADDITIVE, USE AND PROCEDURE OF THE SAME. | |
| EA201791148A1 (en) | METHOD FOR DETERMINING THE ABSOLUTE QUANTITIES OF HLA-RESTRICTED CANCER PEPTIDES FORMED OUT OF THE NATURAL PROCESSING | |
| CL2018000226A1 (en) | Peptide mixture (divisional application 201601405) | |
| CL2017001883A1 (en) | Antisenescent compounds and uses thereof | |
| ES2693321T3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| ES2691070T3 (en) | Anti-inflammatory peptides and composition comprising the same | |
| ES2721309T3 (en) | Composition for preparing tagatose and method for preparing tagatose from fructose | |
| AR113455A1 (en) | IMMUNOMODULATING PROTEINS OF ICOS LIGAND VARIANTS AND RELATED COMPOSITIONS AND METHODS | |
| AR120721A2 (en) | PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF JOINT DAMAGE | |
| AR085167A1 (en) | GINGIVALIS PORPHYROMONAS POLYPEPTIDES, TREATMENT, USE, ANTIBODY AND KIT METHOD | |
| CL2017003228A1 (en) | Ras protein mutant fragments | |
| UY36565A (en) | VARIOUS POLYPEPTIDES DIVIDING TOXINS FROM FUSARIUM, ADDITIVE CONTAINING THESE VARIATIONS AND THEIR USE, AS WELL AS PROCEDURES FOR THE DIVISION OF TOXINS FROM FUSARIUM | |
| AR081856A1 (en) | VACCINE AND METHODS TO REDUCE AN INFECTION BY CAMPYLOBACTER | |
| UY37408A (en) | VECTOR VACCINE AGAINST THE VIRUS OF THE "A" SWINE FLU | |
| PE20170955A1 (en) | NEW INSECT INHIBITOR PROTEINS | |
| MX2016014633A (en) | New cath2 derivatives. | |
| CO2017011964A2 (en) | A method to produce recombinant hcg | |
| CO2021017664A2 (en) | peptides | |
| EA201492068A1 (en) | PEPTID HYDROCHLORIDE SALT AND ITS APPLICATION IN COMBINATION WITH OTHER PEPTIDES IN IMMUNOTHERAPY | |
| AR083766A1 (en) | IMMUNOGENIC PEPTIDE |